Intravitreal Conbercept Injection with and without Grid Laser Photocoagulation in the Treatment of Diffuse Diabetic Macular Edema in Real-Life Clinical Practice

Table 1

Baseline characteristics of patients with DDME included in two treatment groups.

Characteristic	IVC group	Combined group	value
Number of patients,	26	25	—
Number of eyes,	31	30	—
Mean age ± SD (years)	60.9 ± 12.9	62.0 ± 10.5	0.746
Gender, (%)
Men	12 (46.2)	14 (56.0)
Women	14 (53.8)	11 (44.0)	0.482
Diabetes type, (%)
Type I	2 (7.7)	1 (4.0)
Type II	24 (92.3)	24 (96.0)	—
Mean HbA1c ± SD	8.0 ± 0.9	7.9 ± 0.8	0.560
Mean duration of diabetes ± SD (years)	14.0 ± 5.5	13.1 ± 3.7	0.526
Mean duration of DDME ± SD (months)	4.9 ± 3.8	4.7 ± 2.8	0.812
Mean BCVA ± SD (letter score)	48.8 ± 10.0	45.9 ± 10.4	0.283
Mean CRT ± SD (μm)	487.2 ± 101.0	479.3 ± 91.4	0.750

DDME: diffuse diabetic macular edema; IVC: intravitreal conbercept; SD: standard deviation; HbA1c: hemoglobin A1c; BCVA: best-corrected visual acuity; CRT: central retinal thickness.
Independent -test; chi-square analysis.